|Publication number||US4056476 A|
|Application number||US 05/696,256|
|Publication date||Nov 1, 1977|
|Filing date||Sep 2, 1976|
|Priority date||Feb 27, 1975|
|Publication number||05696256, 696256, US 4056476 A, US 4056476A, US-A-4056476, US4056476 A, US4056476A|
|Inventors||Herman Charles Mouwen, William Lauer, Steven Louis Weinberg|
|Original Assignee||Johnson & Johnson, Purolator, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (7), Referenced by (36), Classifications (16), Legal Events (2)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This is a continuation-in-part application of our co-pending application, Ser. No. 553,703, filed Feb. 27, 1975, now abandoned.
This invention relates to an improved blood filter media.
The filtration of blood is a delicate and critical operation. Blood filtration requires that the debris, such as clots and various types of agglomerates, be removed without removing desirable red cells or other desirable portions of the blood and without degradation of the blood.
Whole blood comprises plasma, red cells, white cells and platelets. The red cells have diameters of from about 8 to 10 microns and the white blood cells have diameters of from about 12 to 20 microns. Whole blood, after storage for a relatively short period of time, and blood which is passing through an extracorporeal circuit, such as is used in open heart surgery, or through a dialysis operation will tend to degrade and build debris in the blood. This debris must be filtered from the blood before the blood is returned or given to a patient. The debris may comprise blood clots or various types of aggregates of the platelet type or the leucocyte type and may include agglomeration of protein precipitates and other undesirable debris. In filtering this blood, the ultimate is to remove all of the undesirable debris while not removing any of the desirable red blood cells or white blood cells or the platelets. Hence, media used in the filtration of blood must meet certain requirements. It must have no harmful effects on the blood or degrade the blood. The media should be stable during filtration, that is its pore size distribution range should not be altered. Very often some media will start to plug and after limited use will remove some of the desirable red and white blood cells from the blood. The media should have as much open area as possible to make the most efficient use of the media area and make the filter small and easily handled.
More specifically media used in filtering blood should have a relatively uniform pore size and the media should maintain this pore size throughout the use of the media. In prior art blood filtration medias made from woven fabrics, one technique for accomplishing this is to bond the woven yarns at their cross-over point. This means a binder material must be added to the media and the exact same amount added at each cross-over point. If too much binder is added at a cross-over the pore size is decreased and the pore size distribution range increased upsetting the very delicate balance required in filtering blood. Another technique for obtaining the desired stability in a woven fabric blood filter media is to calender the fabric. This process tends to flatten the yarns at their cross-over point and also disrupts the pore size rating of the media.
Furthermore, the larger the yarns used in producing the filter fabric the more stable it may be made by utilizing the friction of the crossing yarns. However, the larger the yarns the less the open area and the greater the pressure drop across the media which is undesirable when filtering blood.
We have discovered an improved blood filter media. Our improved media has a nominal pore size rating of 20 microns. Our improved media is stable during use and retains this pore size rating even after considerable quantities of blood have been filtered. Our improved filter media has minimal deleterious effects on the blood being filtered. Unexpectedly, our new blood filter media has a very narrow distribution range and while it removes all of the undesirable debris from the blood it does not remove the desirable red blood cells and white blood cells in the blood.
In accordance with the present invention, our improved blood filter media is a woven fabric. The fabric is woven in a regular, even-sided two up and two down twill weave using monofilament yarns having a yarn diameter of 30 to 36 microns. The woven fabric has a nominal pore size rating of 20 microns and a distribution range of from 17 microns to 23 microns. Preferably our improved blood filter media is woven with nylon monofilament yarns having a diameter of 32 microns.
What we have discovered is that if a fabric is woven using 30 to 36 micron diameter monofilament yarns in a regular, even-sided, two up and two down weave to produce a nominal 20 micron pore size rating you unexpectedly obtain a very narrow pore size distribution range of 6 microns and perhaps more unexpectedly are able to maintain both the nominal pore size and the narrow distribution range throughout extended use of the filter media. Furthermore, these unexpected results are obtained without calendering or bonding the fabric, which it is believed would in fact tend to disrupt these desired results.
The invention will be further described in conjunction with the accompanying drawings wherein:
FIG. 1 is a plan view of the improved filter media of the present invention; and
FIG. 2 is a cross-sectional view of a blood filter unit incorporating the media of the present invention.
Referring to the drawings, in FIG. 1, there is shown the improved blood filter media 10 of the present invention. The media is woven with nylon monofilament yarns 11 and these yarns are used in both the warp and the filling directions. The media is woven in a regular, even-sided, two up and two down twill weave. Though nylon monofilament yarns are preferred, the media may also be woven with polyester monofilament yarns or other monofilament yarns which will not degrade or have a deleterious effect on the blood. It is important that monofilament yarns be used as it is believed that such yarns, being smoother and with less rough areas such as are present in multifilament or spun yarns, have a longer life and have less deleterious effects on the blood. The size of the monofilaments should be as small as possible. The smaller the diameter of each yarn, the more open area in the filter while still maintaining a desired pore size. Sizes of from about 30 microns in diameter to 36 microns in diameter have been found suitable in accordance with the present invention.
The media should not be calendered or the yarns bonded or held together at their cross-over points. This is important as it appears that calendering or bonding tends to disrupt the pore size rating and distribution range and, surprisingly, does not have any improved effect on the stability of the two up and two down twill weave. By stability, it is meant that its initially rated pore size is maintained throughout its expected life. The improved blood filter media has a nominal pore size rating of 20 microns. If its rating is less than 20 microns, it will remove desirable portions such as white and red blood cells from the blood being filtered. If its pore size rating is greater than 20 microns, it will not remove all of the undesirable debris. The media should have a particle distribution range of from 17 microns to 23 microns. This is a narrow distribution range; however, it is important to the present invention. A wider distribution range will either remove too many important portions of the blood or not remove sufficient debris or, in some instances, may have both harmful effects. Furthermore, the wider distribution ranges do not maintain that distribution range during extended uses and hence are unsatisfactory.
The two up and two down twill weave using substantially the same size yarns in the warp and fill direction produces a fabric having very uniform openings which is essential to the present invention. The fact that our fabric media is not calendered or heat set allows us to insure the maintenance of this opening in a blood filter unit.
It has been theorized that the above-described twill weave combined with the lack of calendering produces some depth to the fabric media or depth to the openings or pores in the fabric. This slight depth to the pore helps in preventing slightly larger particles than the size of the opening from changing shape and squeezing through an opening or pore.
In FIG. 2, there is shown one embodiment of a blood filter unit 15 that utilizes the blood filter media of the present invention. The unit comprises a housing 16 and a filter cartridge 17 disposed within the housing. At the top of the housing is an inlet opening 18 for the incoming blood and an air vent 19 to allow air to escape from the filter unit. The filter cartridge is cylindrical in shape. The outside walls of the cylinder are formed by the filter media 20 of the present invention. The media may be flat or fluted in its cylindrical form. The inside surface of the media is supported by an open mesh-like cylinder 21. The upper end of the media is sealed by a cap 22. The lower end of the media is sealed into the bottom portion of the housing. In the center of the bottom portion of the housing and positioned adjacent the center of the filter cartridge is the blood outlet opening 23.
In operation, the blood flows in the path as shown by the arrows in the drawing. The blood enters through the inlet 18 and from outside the filter cartridge into the center of the cartridge and out the outlet 23.
Though a cylindrical blood filter unit has been shown, the unit may be of any desired shape and the media may take any configuration as desired.
Having thus described the present invention, it should be understood that many variations and modifications may be made without departing from the scope of the invention itself; the invention is only limited by the scope of the claims appended hereto.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2551175 *||Nov 4, 1949||May 1, 1951||Edmund G Smith||Filter cloth|
|US3132099 *||Nov 14, 1960||May 5, 1964||Friedrich Eilhauer||Filter and method of making same|
|US3593854 *||Dec 5, 1969||Jul 20, 1971||Swank Roy Laver||Blood treating and filtering apparatus|
|US3603354 *||Apr 10, 1968||Sep 7, 1971||Huyck Corp||Apparatus for use on papermaking machines|
|US3765536 *||Jun 16, 1972||Oct 16, 1973||Pall Corp||Blood filter cascade|
|US3851681 *||Apr 18, 1973||Dec 3, 1974||Albany Int Corp||Woven papermaking drainage fabric having four shed weave pattern and weft threads of alternating diameter|
|US3870639 *||Jan 2, 1974||Mar 11, 1975||Moore Perk Corp||Filtering device|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4181514 *||Feb 14, 1978||Jan 1, 1980||Huyck Corporation||Stitch knitted filters for high temperature fluids and method of making them|
|US4253967 *||Apr 9, 1979||Mar 3, 1981||Bentley Laboratories, Inc.||Blood treating method|
|US4283289 *||Aug 22, 1979||Aug 11, 1981||Baxter Travenol Laboratories, Inc.||Blood filter for leukocytes|
|US4344777 *||Jan 7, 1980||Aug 17, 1982||Siposs George G||Directed flow bubble trap for arterial blood|
|US4402827 *||Jul 20, 1981||Sep 6, 1983||Sealed Power Corporation||Transmission fluid filter|
|US4676771 *||Mar 31, 1986||Jun 30, 1987||Gelman Sciences, Inc.||Arterial blood filter|
|US4690762 *||Apr 18, 1986||Sep 1, 1987||Terumo Kabushiki Kaisha||Apparatus for removing bubbles from a liquid|
|US4765895 *||Dec 19, 1983||Aug 23, 1988||Sarstedt||Apparatus for recovery of cell material from body fluids|
|US4964984 *||Jun 14, 1989||Oct 23, 1990||Electromedics, Inc.||Blood filter|
|US5229012 *||Jun 24, 1991||Jul 20, 1993||Pall Corporation||Method for depletion of the leucocyte content of blood and blood components|
|US5344561 *||Jun 7, 1993||Sep 6, 1994||Pall Corporation||Device for depletion of the leucocyte content of blood and blood components|
|US5501795 *||Jul 18, 1994||Mar 26, 1996||Pall Corporation||Device for depletion of the leucocyte content of blood and blood components|
|US5837140 *||May 28, 1996||Nov 17, 1998||Dideco S.P.A||Blood filter and extracorporeal circuit|
|US6015499 *||Apr 17, 1998||Jan 18, 2000||Parker-Hannifin Corporation||Membrane-like filter element for chemical mechanical polishing slurries|
|US6231770||Jul 3, 1997||May 15, 2001||Pall Corporation||Multiple element filter and method of using therefor|
|US6491656 *||Nov 21, 1997||Dec 10, 2002||Therakos, Inc.||Integrated cassette for controlling fluid having an integral filter|
|US6497685||Mar 24, 2000||Dec 24, 2002||Baxter International Inc.||Integral intravenous chamber and filter|
|US6689315||Apr 5, 2002||Feb 10, 2004||Cardiovention, Inc.||Integrated blood handling system having improved pump|
|US6730267||Feb 9, 2001||May 4, 2004||Cardiovention, Inc.||Integrated blood handling system having active gas removal system and methods of use|
|US6773670||Feb 5, 2002||Aug 10, 2004||Cardiovention, Inc. C/O The Brenner Group, Inc.||Blood filter having a sensor for active gas removal and methods of use|
|US6960322||Jul 8, 2003||Nov 1, 2005||Cardiovention, Inc.||Integrated blood handling system having active gas removal system and methods of use|
|US7022099||Mar 17, 2003||Apr 4, 2006||Cardiovention, Inc.||Extracorporeal blood handling system with automatic flow control and methods of use|
|US7485260 *||Oct 30, 2006||Feb 3, 2009||Yehuda Tamari||Venous reservoir|
|US7541000||Sep 26, 2005||Jun 2, 2009||Cardiovention, Inc.||Micro-processor controlled active gas removal apparatus|
|US20040009097 *||Jul 8, 2003||Jan 15, 2004||Cardiovention, Inc.||Integrated blood handling system having active gas removal system and methods of use|
|US20040184953 *||Mar 17, 2003||Sep 23, 2004||Litzie A. Kenneth||Extracorporeal blood handling system with automatic flow control and methods of use|
|US20040228760 *||Jun 21, 2004||Nov 18, 2004||Cardiovention, Inc.||Methods of use of a blood filter having a sensor for active gas removal|
|US20060029515 *||Sep 26, 2005||Feb 9, 2006||Cardiovention, Inc.||Integrated blood handling system having active gas removal system and method of use|
|US20070078369 *||Oct 30, 2006||Apr 5, 2007||Yehuda Tamari||Venous reservoir|
|DE3123269A1 *||Jun 12, 1981||Jun 16, 1982||Sealed Power Corp||Triebwerks-fluidumsfilter|
|EP0017873A1 *||Apr 3, 1980||Oct 29, 1980||Terumo Corporation||A blood filter device|
|EP0079553A1 *||Nov 8, 1982||May 25, 1983||Biotest-Serum-Institut GmbH||Microfiltration device for filtering blood coagels and microaggregates|
|EP0313348A2 *||Oct 20, 1988||Apr 26, 1989||Pall Corporation||Device and method for depletion of the leukocyte content of blood and blood components|
|EP0397403A1 *||May 3, 1990||Nov 14, 1990||Pall Corporation||Device and method for depletion of the leucocyte content of blood and blood components|
|EP1694423A2 *||Dec 7, 2004||Aug 30, 2006||BAXTER INTERNATIONAL INC. (a Delaware corporation)||Blood filter assembly having multiple filtration regions|
|WO2010077718A2||Dec 9, 2009||Jul 8, 2010||E. I. Du Pont De Nemours And Company||Filters for selective removal of large particles from particle slurries|
|U.S. Classification||210/446, 139/425.00A, 210/460, 210/507, 139/383.00A|
|International Classification||A61M1/36, B01D27/02, B01D39/08|
|Cooperative Classification||B01D39/083, B01D2239/1216, B01D2239/1233, A61M1/3627, B01D27/02|
|European Classification||B01D27/02, B01D39/08B, A61M1/36C4|
|Oct 26, 1987||AS||Assignment|
Owner name: PUROLATOR TECHNOLOGIES INC., 950 RANCHO CONEJO BOU
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:PUROLATOR COURIER CORP., A CORP. OF NEW YORK;REEL/FRAME:004811/0307
Effective date: 19850708
|Dec 30, 1987||AS||Assignment|
Owner name: MEDTRONIC, INC., 7000 CENTRAL AVENUE, N.E., MINNEA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:JOHNSON & JOHNSON;REEL/FRAME:004825/0362
Effective date: 19871208
Owner name: MEDTRONIC, INC., A MINNESOTA CORP.,MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JOHNSON & JOHNSON;REEL/FRAME:004825/0362
Effective date: 19871208